全球糖尿病护理设备市场规模、份额和成长分析：按类型、患者照护环境和地区 - 行业预测（2024-2031）

2022年全球糖尿病护理设备市场规模为28亿美元，从2023年的32.6亿美元成长到2031年的109亿美元，在预测期间（2024-2031年）预计复合年增长率为16.3%。

据国际糖尿病联盟 (IDF) 称，无法治疗方法的危及生命的慢性糖尿病已达到流行病水平，影响全球约 5.37 亿成年人。特别是，与久坐生活方式相关的 2 型糖尿病盛行率不断上升，预计将推动对糖尿病护理设备的需求。心臟病、肾衰竭和截肢等慢性糖尿病併发症凸显了对有效管理解决方案的迫切需求。世界卫生组织 (WHO) 强调，由于肥胖率上升和健康意识下降，糖尿病在低收入和中等收入国家变得越来越普遍。随着疾病负担的增加以及旨在提高意识的各种政府倡议，糖尿病护理设备市场预计在未来几年将出现显着增长。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 次要/一级资讯来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 抑制因素和挑战
• 波特的分析和影响
  • 竞争公司之间的敌对关係
  • 替代品的威胁
  • 买方议价能力
  • 新进入者的威胁
  • 供应商的议价能力

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2023）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析
• 技术进步
• 监管环境
• 案例研究

糖尿病护理设备市场规模：按类型，复合年增长率（2024-2031）

• 市场概况
• 血糖值监测系统
  • 自我血糖监测系统
  • 连续血糖监测系统
  • 试纸/试纸
  • 采血针/穿刺装置
• 胰岛素给药装置
  • 胰岛素帮浦
  • 胰岛素笔
  • 胰岛素注射器和针头
• 糖尿病管理行动应用程式

糖尿病护理设备市场规模：依患者照护环境划分，复合年增长率（2024-2031）

• 市场概况
• 自我/家庭保健
• 医院和糖尿病诊所

糖尿病护理设备市场规模，复合年增长率（2024-2031）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 英国
  • 德国
  • 西班牙
  • 法国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• F. Hoffman-La Roche Ltd.
• Abbott
• Ascensia Diabetes Care Holdings AG
• Dexcom, Inc.
• Medtronic PLC
• B. Braun Melsungen AG
• Becton, Dickinson and Company
• Arkray, Inc.
• Sanofi
• Novo Nordisk A/S
• Terumo Corporation
• Ypsomed
• Sinocare, Inc.
• AgaMatrix Holdings LLC
• SD Biosensor, Inc.
• Microgene Diagnostic Systems Pvt. Ltd.
• Dr. Morepen
• Bionime Corporation
• Rossmax International Ltd.

结论和建议

Global Diabetes Care Devices Market size was valued at USD 2.8 billion in 2022 and is poised to grow from USD 3.26 billion in 2023 to USD 10.90 billion by 2031, growing at a CAGR of 16.3% during the forecast period (2024-2031).

Diabetes, a chronic and life-threatening condition with no cure, has reached pandemic levels, affecting approximately 537 million adults globally, according to the International Diabetes Federation (IDF). The growing prevalence, particularly of Type 2 diabetes linked to sedentary lifestyles, is expected to drive demand for diabetes care devices. Chronic diabetes complications, including heart attacks, kidney failure, and amputations, underscore the urgent need for effective management solutions. The World Health Organization highlights that diabetes is more prevalent in low to middle-income countries due to rising obesity rates and limited health awareness. As the disease burden increases, alongside various government initiatives aimed at raising awareness, the diabetes care devices market is anticipated to experience significant growth in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Diabetes Care Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Diabetes Care Devices Market Segmental Analysis

Global Diabetes Care Devices Market is segmented by Type, Patient Care Settings, and region. Based on Type, the market is segmented into Blood glucose monitoring systems, Insulin delivery devices, and Diabetes management mobile applications. Based on Patient Care Settings, the market is segmented into Self/Home Healthcare, and Hospitals & Diabetes Specialty Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Diabetes Care Devices Market

The Global Diabetes Care Devices market is witnessing significant growth driven by the increasing prevalence of sedentary lifestyles and the associated rise in diabetes cases. With more individuals diagnosed with Type-2 diabetes due to unhealthy habits, the need for effective management solutions has become critical. According to the International Diabetes Federation, approximately 537 million adults are living with diabetes, which increases the urgency for care devices. Growing awareness among patients, alongside the demand for insulin-delivery systems, is further propelling market expansion. Emerging economies present significant opportunities due to a higher incidence of diabetes among middle and lower-middle-class populations, combined with a rising interest in technological advancements by manufacturers.

Restraints in the Global Diabetes Care Devices Market

The growth of the Global Diabetes Care Devices market is expected to encounter challenges during the forecast period, primarily due to the inaccessibility and low awareness of diabetes management technologies in remote and underdeveloped regions. Many patients in these areas lack access to essential diabetes care devices, which significantly limits market penetration. Additionally, the lengthy registration processes for new devices, coupled with complications surrounding reimbursement, further exacerbate these challenges. Consequently, these factors collectively hinder the overall adoption and growth of diabetes care devices in markets that are already struggling with healthcare access and awareness.

Market Trends of the Global Diabetes Care Devices Market

The Global Diabetes Care Devices market is experiencing significant growth driven by the rising adoption of self-monitoring blood glucose meters and test strips, alongside increased demand for continuous glucose monitoring (CGM) systems. This trend is particularly pronounced in developing countries, where greater awareness of diabetes management is influencing consumer behavior. Additionally, the WHO highlights the alarming statistic that over 60% of the global population lacks sufficient physical activity, exacerbating the risk of type 2 diabetes associated with increased body weight. As health consciousness continues to grow, market players are poised to capitalize on lucrative opportunities in this expanding sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies

Global Diabetes Care Devices Market Size by Type & CAGR (2024-2031)

• Market Overview
• Blood glucose monitoring systems
  • Self-monitoring blood glucose monitoring systems
  • Continuous glucose monitoring systems
  • Test strips/test papers
  • Lancets/lancing devices
• Insulin delivery devices
  • Insulin pumps
  • Insulin pens
  • Insulin syringes and needles
• Diabetes management mobile applications

Global Diabetes Care Devices Market Size by Patient Care Settings & CAGR (2024-2031)

• Market Overview
• Self/Home Healthcare
• Hospitals & Diabetes Specialty Clinics

Global Diabetes Care Devices Market Size & CAGR (2024-2031)

• North America (Type, Patient Care Settings)
  • US
  • Canada
• Europe (Type, Patient Care Settings)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (Type, Patient Care Settings)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (Type, Patient Care Settings)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Patient Care Settings)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• F. Hoffman-La Roche Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ascensia Diabetes Care Holdings AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dexcom, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arkray, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novo Nordisk A/S
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sinocare, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AgaMatrix Holdings LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SD Biosensor, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Microgene Diagnostic Systems Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Morepen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bionime Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rossmax International Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation